Localization of CRT According to Echocardiography: LOCATE-Pilot Study
Heart Failure
About this trial
This is an interventional treatment trial for Heart Failure
Eligibility Criteria
Inclusion Criteria: male/female patients NYHA class III and IV chronic heart failure symptoms refractory to standard therapy (beta blocker and either ACE-I or ARB on stable dosages for 1 month minimum and duration of 3 months therapy minimum) patient has signed and dated informed consent patient able to receive pectoral device implant QRS>= 130 ms EF <= 35% follow-up at Michigan Heart CHF clinic feasible patient understanding of protocol and willing to comply Exclusion Criteria: recent myocardial infarction (<3 months) recent surgical or percutaneous revascularization (<3months) age < 18 months permanent AF without AV junction ablation life expectancy under 6 months women of child-bearing potential and not willing or able to take birth control mechanical tricuspid valve prior orthotopic heart transplantation intermittent inotropic therapy or inotropic-dependent
Sites / Locations
- Michigan Heart, PC